17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
With 2019 nearly rolled up, it is time to exhale and recap the latest dose of marijuana laws affecti...
Read More >
Technically, no. However, when the contractor is protesting the award of a contract for the same age...
Read More >
Technology dealmaking has continued apace in 2020 as M&A investors take advantage of the sector’s r...
Read More >
Oregon has joined a growing number of states to require employers to provide their workers paid fami...
Read More >
Illinois will soon become the eleventh state to legalize the recreational use of marijuana. On June...
Read More >
The New York State Legislature passed several bills at the end of its 2019 session which, yet again,...
Read More >